Advances in the Treatment of Colorectal Cancer

treatment together with standard chemotherapy (carboplatin and paclitaxel) in women with advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer (OFPC) [15]. However, FDA has not approved bevacizumab for the first-line treatment, so far (decision is expected by June 2018). The results of the Japanese GOG 3016 trial ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download